‹ All stocks

Biohaven Ltd.

BHVN · NYSE · Healthcare

$12.70

▼ $12.70 (-5.29%)

1D 7D 1M 3M 1Y All

Day range

$12.65 – $13.51

Year range

$7.48 – $18.57

Open

$13.41

Previous close

—

Market cap

$1.91B

Volume (24h)

$588.4K

Volume (52w)

$7.47M

Performance

▼ -4.30%

▼ -19.06%

▼ -20.87%

▲ 38.80%

▼ -18.12%

YTD

▲ 17.16%

▼ -45.31%

▲ 73.97%

All-time

▲ 73.97%

Key statistics

P/E ratio

-2.74

EPS (TTM)

$-4.64

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

150.6M

About Biohaven Ltd.

Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems, with the potential to transform current medical interventions.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1139.65	-1.23%
JNJ Johnson & Johnson	$256.11	-1.42%
ABBV AbbVie	$260.91	0.45%
MRK Merck & Co.	$143.38	-0.27%
UNH UnitedHealth Group Incorp…	$368.09	0.81%